Thomas Brian C.
SEC CIK 1996097 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MGX | Metagenomi Therapeutics, Inc. | Dir | 2.51M | — | $30.5K | 5 | 2024-04-01 | 2025-12-05 |
Most active insiders at MGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Reid Laurence | Dir | $23.4K | — |
| 2 | Irish Jian | See Remarks, Dir | — | $12.7K |
| 3 | Wapnick Pamela | CFO | — | $11.3K |
| 4 | Thomas Brian C. | Dir | — | $6,779 |
| 5 | Wein Matthew | See Remarks | — | $2,263 |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-08 | 2025-12-05 | MGX | Metagenomi Therapeutics, Inc. | Thomas Brian C. | Dir | S - Sale | $1.77 | -3,830 | 2.51M | -0.2% | -$6,779 | |
| 2025-12-01 | 2025-09-05 | MGX | Metagenomi Therapeutics, Inc. | Thomas Brian C. | Dir | S - Sale | $1.81 | -2,701 | 2.51M | -0.1% | -$4,889 | |
| 2025-06-09 | 2025-06-06 | MGX | Metagenomi Therapeutics, Inc. | Thomas Brian C. | CEO, Dir | S - Sale | $1.75 | -10.8K | 2.52M | -0.4% | -$18.9K | |
| D | 2025-04-03 | 2025-04-01 | MGX | Metagenomi Therapeutics, Inc. | Thomas Brian C. | CEO, Dir | A - Grant | $0.00 | +32.0K | 2.53M | +1% | $0 |
| D | 2024-04-03 | 2024-04-01 | MGX | Metagenomi Therapeutics, Inc. | Thomas Brian C. | CEO, Dir | A - Grant | $0.00 | +119.0K | 2.50M | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations